tiprankstipranks
Trending News
More News >
Hansa Biopharma (SE:HNSA)
:HNSA
Sweden Market

Hansa Biopharma AB (HNSA) Ownership - Who Owns Hansa Biopharma AB?

Compare
0 Followers

Hansa Biopharma AB (HNSA) Ownership Overview

<0.01%0.25%99.75%
<0.01%
Mutual Funds
0.25% ETFs
99.75% Public Companies and
Individual Investors
The ownership structure of Hansa Biopharma AB (SE:HNSA) stock is a mix of institutional, retail, and individual investors. , and 99.75% is owned by Public Companies and Individual Investors.
The ownership structure of Hansa Biopharma AB (SE:HNSA) stock is a mix of institutional, retail, and individual investors. Approximately 100.00% of the company’s stock is owned by Institutional Investors, <0.01% is owned by Insiders

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
171,164Institution0.25%376,390
1Institution<0.01%2

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1Institution<0.01%2

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
138,350Institution0.20%321,891
30,740Institution0.05%71,521
2,074Institution<0.01%4,667

FAQ

Who Owns Hansa Biopharma (SE:HNSA)?
Currently, no data Available
What percentage of Hansa Biopharma (SE:HNSA) stock is held by institutional investors?
Currently, no data Available
What percentage of Hansa Biopharma (SE:HNSA) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.75% of Hansa Biopharma (SE:HNSA) stock is held by retail investors.
    Who owns the most shares of Hansa Biopharma (SE:HNSA)?
    SPDR owns the most shares of Hansa Biopharma (SE:HNSA).
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis